Protara Therapeutics (TARA) Receivables - Other (2014 - 2019)
Protara Therapeutics (TARA) posted quarterly Receivables - Other of -$7000.0 for Q4 2019, up 86.54% year-over-year from -$3752.6 in Q4 2018, and down 40.0% quarter-over-quarter from -$5000.0 in Q3 2019.
Protara Therapeutics (TARA) Receivables - Other (2014 - 2019) Analysis & Trends
Protara Therapeutics (TARA) has reported Receivables - Other for 6 consecutive years, with -$7000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Receivables - Other rose 86.54% year-over-year to -$7000.0; the TTM figure through Dec 2019 stood at -$17000.0 (up 65.31% YoY), while the FY2019 annual figure was -$17000.0, up 65.31% from the prior year.
- Receivables - Other eased to -$7000.0 in Q4 2019 per TARA's latest filing, from -$5000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $305000.0 in Q1 2015 and bottomed at -$182000.0 in Q4 2015.
- Historically, Receivables - Other has averaged $2111.1 across 5 years, with a median of -$3500.0 in 2017.
- On a YoY basis, Receivables - Other climbed as much as 2133.33% in 2015 and fell as far as 768.75% in 2015.
- Protara Therapeutics' Receivables - Other stood at -$182000.0 in 2015, then soared by 139.56% to $72000.0 in 2016, then slumped by 137.5% to -$27000.0 in 2017, then sank by 92.59% to -$52000.0 in 2018, then soared by 86.54% to -$7000.0 in 2019.
- Business Quant data shows TARA's Receivables - Other at -$7000.0 in Q4 2019, -$5000.0 in Q3 2019, and -$20000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 234.56 Mn | 234.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -7,000.00 |
| Dec 31, 2019 | -7,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Sep 30, 2019 | -5,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Jun 30, 2019 | -20,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Mar 31, 2019 | 15,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Dec 31, 2018 | -52,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Mar 31, 2018 | -4,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Dec 31, 2017 | -27,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Sep 30, 2017 | 61,000.00 |
| Jun 30, 2017 | -3,000.00 |
| Jun 30, 2017 | -3,000.00 |